Trial intelligence / Profile preview

DP vs SP for malaria prevention in pregnant women and infants (PROMOTE-BC1)

NCT02163447Phase 3Completed

Start
Jun 2014
Primary completion
May 2018
Modality
Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of dihydroartemisinin + piperaquine in malaria. Started Jun 2014; status: completed.

02

Drugs

dihydroartemisinin + piperaquine
03

Conditions

malaria

Beyond the preview

Go deeper on NCT02163447.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02163447.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call